Literature DB >> 28594412

Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.

Charlotte Burns1,2,3, Laura Yeates1,3, Catherine Spinks1,3, Christopher Semsarian1,2,3, Jodie Ingles1,2,3.   

Abstract

With the surge of next-generation sequencing (NGS) technologies making almost all genetic tests more affordable and available, cardiac genetic testing now routinely encompasses a large number of genes within a panel setting. The additional sensitivity of this practice is limited and has the potential to inflict a spectrum of uncertainty. We sought to explore attitudes, preferences, recall and psychological consequences of informative and uninformative genetic results amongst probands diagnosed with hypertrophic cardiomyopathy (HCM). We conducted semi-structured interviews and analysed the qualitative data using a framework analysis process. In general, we found probands were more concerned with their clinical diagnosis than gene result and in some, recall and understanding of genetic diagnosis was poor. Several participants expected genetic testing would alleviate uncertainty, often holding an altruistic view of participation in testing, removing their sense of self and failing to appreciate fully the familial implications. With the key utility of HCM genetic testing and counselling being for greater risk prediction for at-risk relatives, effective communication within the family is critical. While communication appeared adequate, further questioning found it was often vague, failing to translate into meaningful action by relatives. Based on these findings, a framework of key outcomes to assist multidisciplinary teams in genetic counselling of probands receiving an HCM gene result was developed.

Entities:  

Mesh:

Year:  2017        PMID: 28594412      PMCID: PMC5520078          DOI: 10.1038/ejhg.2017.66

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  33 in total

Review 1.  Conveying a probabilistic genetic test result to families with an inherited heart disease.

Authors:  Jodie Ingles; Christopher Semsarian
Journal:  Heart Rhythm       Date:  2014-03-13       Impact factor: 6.343

2.  Social determinants of health in the setting of hypertrophic cardiomyopathy.

Authors:  Jodie Ingles; Renee Johnson; Tanya Sarina; Laura Yeates; Charlotte Burns; Belinda Gray; Kylie Ball; Christopher Semsarian
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

Review 3.  New perspectives on the prevalence of hypertrophic cardiomyopathy.

Authors:  Christopher Semsarian; Jodie Ingles; Martin S Maron; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2015-03-31       Impact factor: 24.094

Review 4.  Coping theory and research: past, present, and future.

Authors:  R S Lazarus
Journal:  Psychosom Med       Date:  1993 May-Jun       Impact factor: 4.312

5.  Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

Authors:  Suzanne C O'Neill; Christine Rini; Rachel E Goldsmith; Heiddis Valdimarsdottir; Lawrence H Cohen; Marc D Schwartz
Journal:  Psychooncology       Date:  2009-10       Impact factor: 3.894

6.  New "first families": the psychosocial impact of new genetic technologies.

Authors:  Joanna H Fanos
Journal:  Genet Med       Date:  2012-02       Impact factor: 8.822

7.  Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.

Authors:  Anna Middleton; Katherine I Morley; Eugene Bragin; Helen V Firth; Matthew E Hurles; Caroline F Wright; Michael Parker
Journal:  Eur J Hum Genet       Date:  2015-04-29       Impact factor: 4.246

8.  Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population.

Authors:  Anniken Hamang; Geir Egil Eide; Karin Nordin; Berit Rokne; Cathrine Bjorvatn; Nina Øyen
Journal:  BMC Med Genet       Date:  2010-02-17       Impact factor: 2.103

9.  Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy.

Authors:  Jodie Ingles; Joanne M Lind; Philayrath Phongsavan; Christopher Semsarian
Journal:  Genet Med       Date:  2008-02       Impact factor: 8.822

10.  "What does it mean?": uncertainties in understanding results of chromosomal microarray testing.

Authors:  Marian Reiff; Barbara A Bernhardt; Surabhi Mulchandani; Danielle Soucier; Diana Cornell; Reed E Pyeritz; Nancy B Spinner
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

View more
  8 in total

1.  Perceptions of genetic variant reclassification in patients with inherited cardiac disease.

Authors:  Eugene K Wong; Kirsten Bartels; Julie Hathaway; Charlotte Burns; Laura Yeates; Christopher Semsarian; Andrew D Krahn; Alice Virani; Jodie Ingles
Journal:  Eur J Hum Genet       Date:  2019-03-21       Impact factor: 4.246

Review 2.  Patients' views on variants of uncertain significance across indications.

Authors:  Kristin Clift; Sarah Macklin; Colin Halverson; Jennifer B McCormick; Abd Moain Abu Dabrh; Stephanie Hines
Journal:  J Community Genet       Date:  2019-08-20

3.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

4.  Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.

Authors:  Julia Wynn; David T Holland; Jimmy Duong; Priyanka Ahimaz; Wendy K Chung
Journal:  J Genet Couns       Date:  2017-12-15       Impact factor: 2.537

5.  Detection of copy number variants using chromosomal microarray analysis for the prenatal diagnosis of congenital heart defects with normal karyotype.

Authors:  Tingting Song; Shanning Wan; Yu Li; Ying Xu; Yinghui Dang; Yunyun Zheng; Chunyan Li; Jiao Zheng; Biliang Chen; Jianfang Zhang
Journal:  J Clin Lab Anal       Date:  2018-07-25       Impact factor: 2.352

6.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  J Arrhythm       Date:  2021-04-08

Review 7.  A Person-Centered Approach to Cardiovascular Genetic Testing.

Authors:  Julia Platt
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

8.  Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis.

Authors:  Chloe Mighton; Salma Shickh; Elizabeth Uleryk; Petros Pechlivanoglou; Yvonne Bombard
Journal:  Genet Med       Date:  2020-09-14       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.